Jennifer Wilson

Jennifer Wilson is a seasoned Senior-level Healthcare Management Professional with a focus on driving Strategic Sales & Marketing Initiatives in the oncology sector, including solid tumor, hematology, next-generation sequencing, and targeted agents. With a background in molecular diagnostics for oncology, she excels in Client Management/Development, Key Opinion & Thought Leader Engagement, Educational Program Coordination, Speaker Management, and Disease Education.

With extensive experience in the oncology diagnostic space, Jennifer possesses in-depth knowledge of genomic assays and technology platforms, community oncology business models, market access, reimbursement, and national/regional payers. Her strategic network includes top Key Opinion Leaders (KOLs), physician networks, and Academic Medical Centers (AMCs), reflecting her credibility and influence in the global medical community.

Jennifer Wilson's career highlights include roles such as Senior Consultant at Collaborative Cancer Solutions, Clinical Director of Multi-Disciplinary Programs & Tumor Boards at 21st Century Oncology, and Director of Medical Oncology at Baptist Health South Florida. She is recognized as an innovative leader and proven change agent with a track record of exceeding metrics and delivering exceptional results as part of senior management teams.

Jennifer's educational background includes a Bachelor of Science Degree in Nursing with a focus on Pre-Medicine/Pre-Medical Studies from Vanderbilt University, underscoring her strong foundation in healthcare and medicine.

Throughout her career, Jennifer Wilson has demonstrated a unique ability to identify opportunities, develop creative marketing strategies, and navigate the evolving competitive landscape in healthcare. Her expertise, leadership skills, and strategic insights position her as a valued professional in the healthcare management sector.

Jennifer Wilson's professional journey showcases her dedication to improving healthcare outcomes, fostering collaborations, and driving growth in the oncology domain. Her reputation as a respected and visionary leader underscores her significant contributions to the field.